bioAffinity Technologies ... (BIAF)

0.28

0.00 (1.30%)

At close: Mar 24, 2025, 3:59 PM

0.28

2.56%

After-hours: Mar 24, 2025, 04:50 PM EDT

Company Description

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics.

The company offers CyPath lung, a diagnostic test, for early detection of lung cancer.

It also researches targeted therapies to treat cancer at the cellular level.

The company was founded in 2014 and is based in San Antonio, Texas.

bioAffinity Technologies Inc.

Country	United States
IPO Date	Sep 1, 2022
Industry	Medical - Diagnostics & Research
Sector	Healthcare
Employees	75
CEO	Maria Zannes J.D.

Address: 22211 West Interstate 10 San Antonio, Texas United States
Website	https://www.bioaffinitytech.com

Name	Position
Maria Zannes J.D.	Founder, President, Chief Executive Officer & Director
J. Michael Edwards CPA, M.B.A.	Chief Financial Officer & Principal Accounting Officer
Xavier T. Reveles M.S.	Chief Operating Officer
Dallas J. Coleman	Vice President of sales
Dr. William Bauta Ph.D.	Chief Science Officer
Julie Anne Overton	Director of Communications
Steven Girgenti	Founder & Executive Chairman of the Board
Timothy P. Zannes J.D.	Executive Vice President, Secretary & General Counsel